Latest Financing Round Will Support Tessera’s Build Out of its GENE WRITING Platforms and Pursuit of Multiple Therapeutic Programs for Clinical Development SOMERVILLE, Mass.--(BUSINESS WIRE)--Tessera ...

Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. For several years, a rivalry has been ...

Presented improved editing data in non-human primates (NHP) for sickle cell disease (SCD), demonstrating a single dose of Gene Writer achieved an ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Tessera Therapeutics, an early-stage life sciences company founded by Flagship Pioneering, announced today that it has raised over $230M in Series B financing. The ...

Tessera’s reported revenue of $53.2 million was down 26.8% sequentially and 6.2% year over year. Tessera expects the Intellectual Property business to gradually become a smaller part of its revenue, ...

Tessera Therapeutics, founded and created by life sciences VC staple Flagship Pioneering, is building a war chest with a fresh $300 million for its trio of gene writing platforms. The latest ...

Elon Musk’s SpaceX is weighing an initial public offering (IPO) at a valuation of over $1.5 trillion. Microsoft-backed OpenAI is also rumored to be seeking a trillion-dollar public debut. Given that ...

Tessera Therapeutics is planning to lay off 90 employees, the Flagship-founded biotech has warned. In a state layoff notice posted Wednesday, Tessera explained that the workforce reduction will affect ...

Tessera Technologies, Inc. TSRA recently acquired Ziptronix, Inc. in a cash transaction worth $39 million. This will enhance Tessera’s advanced packaging capabilities with the addition of ...

Kabir Nagrecha is tackling the $1.4 trillion “consulting tax” on the IT transformation market with AI agents built to do something for which armies of Accenture-style consultants have long billed ...